Meuwissen Martijn, Chamuleau Steven A J, Siebes Maria, de Winter Robbert J, Koch Karel T, Dijksman Lea M, van den Berg Anja J, Tijssen Jan G P, Spaan Jos A E, Piek Jan J
Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Catheter Cardiovasc Interv. 2008 Feb 15;71(3):291-7. doi: 10.1002/ccd.21331.
We evaluated deferral of PCI of intermediate coronary lesions (IL) using fractional (FFR) and coronary flow reserve (CFR) hyperemic stenosis resistance index (HSR) in patients with a negative or nondiagnostic and noninvasive stress tests.
Outcome after deferral of PCI of IL with discordant results between FFR and CFR is unknown.
PCI was deferred in 186 IL (mean diameter stenosis: 52%). Patients were divided according to the results of FFR and CFR in group A; FFR >or= 0.75 and CFR >or= 2.0 (n = 129), group B; FFR >or= 0.75 and CFR 2.0 (n = 28), group C; FFR 0.75 and CFR >or= 2.0 (n = 23) and group D; FFR 0.75 and CFR 2.0 (n = 6). Patients were followed for one year to document major adverse cardiac events (MACE).
Nineteen MACEs (0 deaths, 4 myocardial infarctions, 1 CABG, and 14 PCIs) occurred during a follow up of 323 +/- 88 days. MACE rate was lowest (4.7%) when FFR, CFR, and HSR were normal. A higher MACE rate was observed when concordant abnormal (group D) or discordant results between FFR and CFR (group B and C) were compared to concordant normal values (group A, 33.3% vs. 19.7% vs. 5.4%, P = 0.008). Multivariate regression analysis showed a higher predictive power for HSR than for FFR and CFR.
Abnormal FFR or abnormal CFR was documented in 31% of intermediate coronary lesions. Deferral of PCI in this group was associated with a high MACE rate, which underscores the rationale of combined pressure and flow measurements providing a stenosis resistance index that is better suited for clinical decision making in these lesions.
我们评估了在无创应激试验结果为阴性或非诊断性的患者中,使用血流储备分数(FFR)、冠状动脉血流储备(CFR)和充血性狭窄阻力指数(HSR)对中度冠状动脉病变(IL)行PCI延迟的情况。
FFR和CFR结果不一致的IL行PCI延迟后的结局尚不清楚。
186例IL的PCI被延迟(平均直径狭窄:52%)。根据FFR和CFR结果将患者分为A组:FFR≥0.75且CFR≥2.0(n = 129);B组:FFR≥0.75且CFR<2.0(n = 28);C组:FFR<0.75且CFR≥2.0(n = 23);D组:FFR<0.75且CFR<2.0(n = 6)。对患者进行一年的随访以记录主要不良心脏事件(MACE)。
在323±88天的随访期间发生了19例MACE(0例死亡、4例心肌梗死、1例冠状动脉搭桥术和14例PCI)。当FFR、CFR和HSR正常时,MACE发生率最低(4.7%)。与FFR和CFR结果一致正常(A组)相比,当结果一致异常(D组)或FFR和CFR结果不一致(B组和C组)时,观察到更高的MACE发生率(33.3%对19.7%对5.4%,P = 0.008)。多变量回归分析显示HSR的预测能力高于FFR和CFR。
31%的中度冠状动脉病变记录到FFR异常或CFR异常。该组PCI延迟与高MACE发生率相关,这突出了联合压力和血流测量提供更适合这些病变临床决策的狭窄阻力指数的基本原理。